Thanks so much for your interest in the ex vivo OT-1 cross-priming assay. In this experiment, we isolated the CD11b−CD11c+ DCs (mostly cDC1), CD11b+CD11c+ DCs, or CD11b+CD11c− F4/80+ TAMs from the irradiated MC38-OVA tumors by cell sorting (BD FACSAria III/Jazz) 5 days after 8 Gy or sham irradiation ± anti-SIRPα and anti–PD-1 (fig. S19). Splenic OT-1 cells were harvested from 6- to 12-week-old C57BL/6-Tg(TcraTcrb)1100Mjb/J mice (#003831) using the CD8α+ T Cell Isolation Kit. The unstimulated OT-1 cells were cocultured with different APC subsets (OT-1:APC = 140,000:70,000) or anti-SIRPα (20 μg/ml) and/or anti–PD-1 (12.5 μg/ml) antibodies alone in RPMI 1640 with 10% FBS and 1% penicillin-streptomycin plus 50 μM β-mercaptoethanol for 48 hours in a 96-well plate. Cells were treated with GolgiPlug 6 hours before intracellular cytokine staining, and the levels of PD-1, CD44, ICOS, Granzyme B, Ki-67, and IFN-γ in OT1 cells were analyzed using flow cytometry. Secreted cytokines in the supernatant were measured using the CBA Mouse Th1/Th2/Th17 Cytokine Kit (BD Biosciences #560485). The protocol of the cytometric bead array can be found on the BD website (https://www.bdbiosciences.com/en-au/products/reagents/immunoassay-reagents/cba/cba-kits/mouse-th1-th2-th17-cba-kit.560485).
Best regards,
Rodney
Copyright: Content may be subjected to copyright.
How to cite:
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Hsieh, R and Curran, M(2022). Ex vivo OT-1 cross-priming assay and secreted cytokine measurement. Bio-protocol Preprint. bio-protocol.org/prep1779.
Hsieh, R. C., Krishnan, S., Wu, R., Boda, A. R., Liu, A., Winkler, M., Hsu, W., Lin, S. H., Hung, M., Chan, L., Bhanu, K. R., Srinivasamani, A., De Azevedo, R. A., Chou, Y., DePinho, R. A., Gubin, M., Vilar, E., Chen, C. H., Slay, R., Jayaprakash, P., Hegde, S. M., Hartley, G., Lea, S. T., Prasad, R., Morrow, B., Couillault, C. A., Steiner, M., Wang, C., Venkatesulu, B. P., Taniguchi, C., Kim, Y. S. B., Chen, J., Rudqvist, N. and Curran, M. A.(2022). ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer. Science Immunology 7(72). DOI: 10.1126/sciimmunol.abl9330
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.